GovWire

Guidance: Medicines eligible for Northern Ireland MHRA Authorised Route

Department Of Health

July 31
15:02 2023

Details

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Published 16 December 2021
Last updated 31 July 2023 +show all updates
  1. The following product was added to the list: Voriconazole 200mg/5ml oral suspension. Removed from the list: Canagliflozin 300mg tablets.

  2. The following products have been removed from the list: Ertugliflozin 5mg tablets; (Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices; Sarclisa 500mg/25ml concentrate for solution for infusion vials (Isatuximab 500mg/25ml solution for infusion vials); Omalizumab 75mg/0.5ml solution for injection pre-filled syringes; (Keytruda 100mg/4ml concentrate for solution for infusion vials) Pembrolizumab 100mg/4ml solution for infusion vials; Sitagliptin 25mg tablets; Sitagliptin 50mg tablets; Sugammadex 200mg/2ml solution for injection vials; and Sugammadex 500mg/5ml solution for injection vials.

  3. Added to the list: (Venclyxto 100mg tablets) Venetoclax 100mg tablets; (Venclyxto 10mg tablets) Venetoclax 10mg tablets; and (Venclyxto 50mg tablets) Venetoclax 50mg tablets.

  4. Added:(Adempas 2.5mg tablets) Riociguat 2.5mg tablets; Fondaparinux sodium 5mg/0.4ml solution for injection pre-filled syringes and; Fosaprepitant 150mg powder for solution for infusion vials.

  5. Added to the list: Sarclisa 500mg/25ml concentrate for solution for infusion vials - Isatuximab 500mg/25ml solution for infusion vials

  6. Added to the list:(Toujeo 300units/ml solution for injection 3ml pre-filled DoubleStar pens) Insulin glargine 300units/ml solution for injection 3ml pre-filled disposable devices;(Fiasp FlexTouch 100units/ml solution for injection 3ml pre-filled pens) Insulin aspart 100units/ml solution for injection 3ml pre-filled disposable devices;(Avamys 27.5micrograms/dose nasal spray) Fluticasone furoate 27.5micrograms/dose nasal spray;Tedizolid 200mg tablets.Removed from the list:(Palexia SR 100mg tablets) Tapentadol 100mg modified-release tablets;(Palexia SR 150mg tablets) Tapentadol 150mg modified-release tablets;(Palexia SR 200mg tablets) Tapentadol 200mg modified-release tablets;(Palexia SR 50mg tablets) Tapentadol 50mg modified-release tablets;(Palexia 50mg tablets) Tapentadol 50mg tablets;(Palexia 75mg tablets) Tapentadol 75mg tablets.

  7. The following products have been added to the list: Gemcitabine 1.2g/120ml infusion bags; Gemcitabine 1.4g/140ml infusion bags; Gemcitabine 1.6g/160ml infusion bags; Gemcitabine 1.8g/180ml infusion bags; Gemcitabine 2.2g/220ml infusion bags; Gemcitabine 2g/200ml infusion bags; and Semaglutide 1mg/0.74ml solution for injection 3ml pre-filled disposable device.

  8. (Palexia SR 100mg tablets) Tapentadol 100mg modified-release tablets; (Palexia SR 150mg tablets) Tapentadol 150mg modified-release tablets; (Palexia SR 200mg tablets) Tapentadol 200mg modified-release tablets; (Palexia SR 50mg tablets) Tapentadol 50mg modified-release tablets; (Palexia 50mg tablets) Tapentadol 50mg tablets; (Palexia 75mg tablets) Tapentadol 75mg tablets

  9. Added to the list: Glecaprevir 100mg / Pibrentasvir 40mg tablets.

  10. The following products have been added to the list: (Epistatus 2.5mg/0.25ml oromucosal solution pre-filled oral syringes) Midazolam 2.5mg/0.25ml oromucosal solution pre-filled oral syringes sugar free; (Epistatus 5mg/0.5ml oromucosal solution pre-filled oral syringes) Midazolam 5mg/0.5ml oromucosal solution pre-filled oral syringes sugar free; and (Epistatus 7.5mg/0.75ml oromucosal solution pre-filled oral syringes) Midazolam 7.5mg/0.75ml oromucosal solution pre-filled oral syringes sugar free. The following product has been changed: Exenatide 2mg injection to Exenatide 2mg/0.85ml prolonged-release suspension for injection pre-filled disposabl

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: